Bill Gates Cites Importance of Alzheimer’s Clinical Trials

  • Press Release
Published on:

Lauds BrightFocus-Sponsored Film Turning Point

In a new Gates Notes published today, philanthropist Bill Gates outlined the great challenges facing scientists in the search for better treatments, and ultimately a cure, for Alzheimer’s disease.

Writing about the critical importance of recruiting volunteers for clinical research, Mr. Gates specifically cited the BrightFocus-sponsored Turning Point, a new documentary by acclaimed filmmaker James Keach which follows scientists and clinical trial volunteers as they work to develop a more effective drug for the disease.

Gates said he was “especially moved” by the film which he said, “does a great job of highlighting the challenges and showing how heroic the participants and their caregivers are.”

His column ends with a call to consider volunteering for a research project, saying, “by pitching in to fight this disease, you can know that you might make life a little better for future generations.” 

To find an Alzheimer’s clinical trial near you, visit the BrightFocus clinical trial finder. Additionally, you can see a trailer of the film, learn more about clinical trials, and view our free publication, Clinical Trials: Your Questions Answered.

Commenting on the film upon its release, Gates said, “Turning Point is an excellent documentary that gives us an inside look at the doctors, scientists, and patients who are working to uncover the mysteries of Alzheimer’s disease through clinical trials. Their determination, even in the face of setbacks, can be an inspiration to everyone affected by this devastating disease and should give us all hope that these trials are bringing us closer to a treatment. Everybody should see this film.”

Working with Gates Ventures and key public and private sector leaders, BrightFocus has screened the film nationally and internationally before community audiences, health care and scientific groups, and policymakers.  To date, the film has been shown 100 times to an audience of over 15,000 people.

Since its inception, BrightFocus has supported over $130 million in innovative Alzheimer’s research worldwide, pursuing the untried, the unexpected, and the most promising science.